{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:15:42Z","timestamp":1772270142002,"version":"3.50.1"},"reference-count":41,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP-106479"],"award-info":[{"award-number":["MOP-106479"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"IUCPQ Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>\n                    <jats:bold>Background.<\/jats:bold>\n                    Men and women differ in their susceptibility to cardiovascular disease, though the underlying mechanism has remained elusive. Heart disease symptoms, evolution and response to treatment are often sex-specific. This has been studied in animal models of hypertension or myocardial infarction in the past but has received less attention in the context of heart valve regurgitation. The aim of the study was to evaluate the development of cardiac hypertrophy (CH) in response to left ventricle (LV) volume overload (VO) caused by chronic aortic valve regurgitation (AR) in male and female rats treated or not with angiotensin II receptor blocker (ARB), valsartan. We studied eight groups of Wistar rats: male or female, AR or sham-operated (sham) and treated or not with valsartan (30 mg\/kg\/day) for 9 weeks starting one week before AR surgical induction.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.<\/jats:bold>\n                    As expected, VO from AR resulted for both male and female rats in significant LV dilation (39% vs. 40% end-diastolic LV diameter increase, respectively;\n                    <jats:italic>p<\/jats:italic>\n                    \u00a0&lt;\u00a00.0001) and CH (53% vs. 64% heart weight increase, respectively;\n                    <jats:italic>p<\/jats:italic>\n                    \u00a0&lt;\u00a00.0001) compared to sham. Sex differences were observed in LV wall thickening in response to VO. In untreated AR males, relative LV wall thickness (a ratio of wall thickness to end-diastolic diameter) was reduced compared to sham, whereas this ratio in females remained unchanged. ARB treatment did not prevent LV dilation in both male and female animals but reversed LV wall thickening in females. Systolic and diastolic functions in AR animals were altered similarly for both sexes. ARB treatment did not improve systolic function but helped normalizing diastolic parameters such as left atrial mass and E wave slope in female AR rats. Increased LV gene expression of\u00a0\n                    <jats:italic>Anp<\/jats:italic>\n                    and\n                    <jats:italic>Bnp<\/jats:italic>\n                    was normalized by ARB treatment in AR females but not in males. Other hypertrophy gene markers (\n                    <jats:italic>Fos, Trpc6, Klf15, Myh6<\/jats:italic>\n                    and\n                    <jats:italic>Myh7<\/jats:italic>\n                    ) were not modulated by ARB treatment. The same was true for genes related to LV extracellular matrix remodeling (\n                    <jats:italic>Col1a1, Col3a1, Fn1, Mmp2, Timp1<\/jats:italic>\n                    and\n                    <jats:italic>Lox<\/jats:italic>\n                    ). In summary, ARB treatment of rats with severe AR blocked the female-specific hypertrophic response characterized by LV chamber wall thickening. LV dilation, on the other hand, was not significantly decreased by ARB treatment. This also indicates that activation of the angiotensin II receptor is probably more involved in the early steps of LV remodeling caused by AR in females than in males.\n                  <\/jats:p>","DOI":"10.7717\/peerj.7461","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T04:14:47Z","timestamp":1564978487000},"page":"e7461","source":"Crossref","is-referenced-by-count":9,"title":["Sex differences in the response to angiotensin II receptor blockade in a rat model of eccentric cardiac hypertrophy"],"prefix":"10.7717","volume":"7","author":[{"given":"\u00c9lisabeth","family":"Walsh-Wilkinson","sequence":"first","affiliation":[{"name":"Universit\u00e9 Laval, Groupe de recherche sur les valvulopathies, Centre de recherche, Institut universitaire de cardiologie et de pneumologie de Quebec, Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Claude","family":"Drolet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Laval, Groupe de recherche sur les valvulopathies, Centre de recherche, Institut universitaire de cardiologie et de pneumologie de Quebec, Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlie","family":"Le Houillier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Laval, Groupe de recherche sur les valvulopathies, Centre de recherche, Institut universitaire de cardiologie et de pneumologie de Quebec, Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c8ve-Marie","family":"Roy","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Laval, Groupe de recherche sur les valvulopathies, Centre de recherche, Institut universitaire de cardiologie et de pneumologie de Quebec, Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Arsenault","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Laval, Groupe de recherche sur les valvulopathies, Centre de recherche, Institut universitaire de cardiologie et de pneumologie de Quebec, Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Couet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Laval, Groupe de recherche sur les valvulopathies, Centre de recherche, Institut universitaire de cardiologie et de pneumologie de Quebec, Qu\u00e9bec, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4443","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"issue":"1","key":"10.7717\/peerj.7461\/ref-1","first-page":"128","article-title":"Experimental aortic regurgitation in rats under echocardiographic guidance","volume":"11","author":"Arsenault","year":"2002","journal-title":"The Journal of Heart Valve Disease"},{"issue":"5","key":"10.7717\/peerj.7461\/ref-2","first-page":"1021","article-title":"Angiotensin II\u2014converting enzyme inhibition improves survival, ventricular remodeling, and myocardial energetics in experimental aortic regurgitationclinical perspective","volume":"6","author":"Arsenault","year":"2013","journal-title":"Circulation: Heart Failure"},{"issue":"1","key":"10.7717\/peerj.7461\/ref-3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41598-017-00855-9","article-title":"Female rats with severe left ventricle volume overload exhibit more cardiac hypertrophy but fewer myocardial transcriptional changes than males","volume":"7","author":"Beaumont","year":"2017","journal-title":"Scientific Reports"},{"issue":"9","key":"10.7717\/peerj.7461\/ref-4","doi-asserted-by":"publisher","first-page":"e14088","DOI":"10.14814\/phy2.14088","article-title":"Testosterone deficiency reduces cardiac hypertrophy in a rat model of severe volume overload","volume":"7","author":"Beaumont","year":"2019","journal-title":"Physiological Reports"},{"issue":"8","key":"10.7717\/peerj.7461\/ref-5","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1161\/CIRCRESAHA.116.307509","article-title":"The importance of biological sex and estrogen in rodent models of cardiovascular health and disease","volume":"118","author":"Blenck","year":"2016","journal-title":"Circulation Research"},{"issue":"1","key":"10.7717\/peerj.7461\/ref-6","doi-asserted-by":"publisher","first-page":"H125","DOI":"10.1152\/ajpheart.00199.2010","article-title":"A high-fructose diet worsens eccentric left ventricular hypertrophy in experimental volume overload","volume":"300","author":"Bouchard-Thomassin","year":"2011","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"3","key":"10.7717\/peerj.7461\/ref-7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cardiores.2005.12.015","article-title":"Integrin signalling: the tug-of-war in heart hypertrophy","volume":"70","author":"Brancaccio","year":"2006","journal-title":"Cardiovascular Research"},{"issue":"1\u20132","key":"10.7717\/peerj.7461\/ref-8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1023\/A:1025438000942","article-title":"Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy","volume":"251","author":"Brower","year":"2003","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"3","key":"10.7717\/peerj.7461\/ref-9","doi-asserted-by":"publisher","first-page":"H669","DOI":"10.1152\/ajpheart.01046.2008","article-title":"Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the \u03b2-adrenergic and renin-angiotensin systems","volume":"296","author":"Champetier","year":"2009","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"4","key":"10.7717\/peerj.7461\/ref-10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10495-009-0441-8","article-title":"Gender differences in apoptotic signaling in heart failure due to volume overload","volume":"15","author":"Dent","year":"2010","journal-title":"Apoptosis"},{"issue":"5","key":"10.7717\/peerj.7461\/ref-11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.cardfail.2009.12.017","article-title":"Gender differences in cardiac dysfunction and remodeling due to volume overload","volume":"16","author":"Dent","year":"2010","journal-title":"Journal of Cardiac Failure"},{"issue":"3","key":"10.7717\/peerj.7461\/ref-12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0008-6363(02)00789-7","article-title":"Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril","volume":"57","author":"Der\u00a0Sarkissian","year":"2003","journal-title":"Cardiovascular Research"},{"key":"10.7717\/peerj.7461\/ref-13","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-1230-1","article-title":"Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation","volume":"4","author":"Drolet","year":"2015","journal-title":"Springerplus"},{"issue":"3","key":"10.7717\/peerj.7461\/ref-14","first-page":"345","article-title":"Gender-related differences in left ventricular remodeling in chronic severe aortic valve regurgitation in rats","volume":"15","author":"Drolet","year":"2006","journal-title":"Journal of Heart Valve Disease"},{"issue":"2","key":"10.7717\/peerj.7461\/ref-15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1054\/jcaf.2002.32195","article-title":"Gender differences in cardiac remodeling secondary to chronic volume overload","volume":"8","author":"Gardner","year":"2002","journal-title":"Journal of Cardiac Failure"},{"issue":"2","key":"10.7717\/peerj.7461\/ref-16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/00004872-200402000-00017","article-title":"Comparison of the effects of omapatrilat and irbesartan\/hydrochlorothiazide on endothelial function and cardiac hypertrophy in the stroke-prone spontaneously hypertensive rat: sex differences","volume":"22","author":"Graham","year":"2004","journal-title":"Journal of Hypertension"},{"key":"10.7717\/peerj.7461\/ref-17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.yfrne.2017.04.001","article-title":"Sex differences in cardiovascular disease-Impact on care and outcomes","volume":"46","author":"Humphries","year":"2017","journal-title":"Frontiers in Neuroendocrinology"},{"issue":"5","key":"10.7717\/peerj.7461\/ref-18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/eurheartj\/ehv548","article-title":"Heart failure: when form fails to follow function","volume":"37","author":"Katz","year":"2016","journal-title":"European Heart Journal"},{"issue":"5","key":"10.7717\/peerj.7461\/ref-19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/CIRCHEARTFAILURE.108.845487","article-title":"Moderate exercise training improves survival and ventricular remodeling in an animal model of left ventricular volume overload","volume":"2","author":"Lachance","year":"2009","journal-title":"Journal of Cardiac Failure"},{"issue":"3","key":"10.7717\/peerj.7461\/ref-20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1172\/JCI19429","article-title":"Sex is a potent modifier of the cardiovascular system","volume":"112","author":"Leinwand","year":"2003","journal-title":"Journal of Clinical Investigation"},{"issue":"17","key":"10.7717\/peerj.7461\/ref-21","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.7717\/peerj.7461\/ref-22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/0366-6999.223862","article-title":"Influence of Valsartan on myocardial apoptosis in spontaneously hypertensive rats","volume":"115","author":"Li","year":"2002","journal-title":"Chinese Medical Journal"},{"issue":"5","key":"10.7717\/peerj.7461\/ref-23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/HYPERTENSIONAHA.115.06967","article-title":"Report of the National Heart, Lung, and Blood Institute Working Group on sex differences research in cardiovascular disease: scientific questions and challenges","volume":"67","author":"Maric-Bilkan","year":"2016","journal-title":"Hypertension"},{"issue":"9819","key":"10.7717\/peerj.7461\/ref-24","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","article-title":"Rheumatic heart disease","volume":"379","author":"Marijon","year":"2012","journal-title":"The Lancet"},{"key":"10.7717\/peerj.7461\/ref-25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.03.019","article-title":"Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease","volume":"164","author":"Michel","year":"2016","journal-title":"Pharmacology & Therapeutics"},{"issue":"suppl_A","key":"10.7717\/peerj.7461\/ref-26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/eurheartj\/4.suppl_A.143","article-title":"Prevention of the development of heart failure and the regression of cardiac hypertrophy by captopril in the spontaneously hypertensive rat","volume":"4","author":"Pfeffer","year":"1983","journal-title":"European Heart Journal"},{"issue":"5","key":"10.7717\/peerj.7461\/ref-27","doi-asserted-by":"publisher","first-page":"H776","DOI":"10.1152\/ajpheart.1982.242.5.H776","article-title":"Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats","volume":"242","author":"Pfeffer","year":"1982","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"10","key":"10.7717\/peerj.7461\/ref-28","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1073\/pnas.79.10.3310","article-title":"Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat","volume":"79","author":"Pfeffer","year":"1982","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.7717\/peerj.7461\/ref-29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1054\/jcaf.2003.17","article-title":"Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats","volume":"9","author":"Plante","year":"2003","journal-title":"Journal of Cardiac Failure"},{"issue":"3","key":"10.7717\/peerj.7461\/ref-30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1139\/y04-005","article-title":"Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation","volume":"82","author":"Plante","year":"2004","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"issue":"1","key":"10.7717\/peerj.7461\/ref-31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.108.801548","article-title":"Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation","volume":"2","author":"Plante","year":"2009","journal-title":"Journal of Cardiac Failure"},{"issue":"4","key":"10.7717\/peerj.7461\/ref-32","doi-asserted-by":"publisher","first-page":"H1888","DOI":"10.1152\/ajpheart.01286.2007","article-title":"Benefits of long-term beta-blockade in experimental chronic aortic regurgitation","volume":"294","author":"Plante","year":"2008","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"11","key":"10.7717\/peerj.7461\/ref-33","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/01.CIR.0000141733.55236.9D","article-title":"Effectiveness of \u03b2-blockade in experimental chronic aortic regurgitation","volume":"110","author":"Plante","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.7717\/peerj.7461\/ref-34","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1253\/circj.CJ-10-0196","article-title":"Sex and gender differences in myocardial hypertrophy and heart failure","volume":"74","author":"Regitz-Zagrosek","year":"2010","journal-title":"Circulation Journal"},{"issue":"3","key":"10.7717\/peerj.7461\/ref-35","doi-asserted-by":"publisher","first-page":"e0120362","DOI":"10.1371\/journal.pone.0120362","article-title":"Chronic treatment with atrial natriuretic peptide in spontaneously hypertensive rats: beneficial renal effects and sex differences","volume":"10","author":"Romero","year":"2015","journal-title":"PLOS ONE"},{"issue":"1","key":"10.7717\/peerj.7461\/ref-36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.7717\/peerj.7461\/ref-37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jacc.2006.06.083","article-title":"Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload","volume":"49","author":"Ryan","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.7717\/peerj.7461\/ref-38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","article-title":"Molecular mechanisms of myocardial remodeling","volume":"79","author":"Swynghedauw","year":"1999","journal-title":"Physiological Reviews"},{"key":"10.7717\/peerj.7461\/ref-39","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1097\/00005344-200301000-00014","article-title":"Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis","volume":"41","author":"Tachikawa","year":"2003","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"2","key":"10.7717\/peerj.7461\/ref-40","first-page":"207","article-title":"Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation clinical perspective","volume":"4","author":"Zendaoui","year":"2011","journal-title":"Circulation: Heart Failure"},{"issue":"2","key":"10.7717\/peerj.7461\/ref-41","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-017-0513-y","article-title":"Group A streptococcus, acute rheumatic fever and rheumatic heart disease: epidemiology and clinical considerations","volume":"19","author":"Z\u00fchlke","year":"2017","journal-title":"Current Treatment Options in Cardiovascular Medicine"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/7461.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/7461.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/7461.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/7461.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T04:15:01Z","timestamp":1564978501000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/7461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":41,"alternative-id":["10.7717\/peerj.7461"],"URL":"https:\/\/doi.org\/10.7717\/peerj.7461","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.7287\/peerj.7461v0.1\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.7461v0.1\/reviews\/1","asserted-by":"object"}]},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]},"article-number":"e7461"}}